These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Probiotics, prebiotics and symbiotics in inflammatory bowel diseases: state-of-the-art and new insights. Sinagra E; Tomasello G; Cappello F; Leone A; Cottone M; Bellavia M; Rossi F; Facella T; Damiani P; Zeenny MN; Damiani F; Abruzzo A; Damiano G; Palumbo VD; Cocchi M; Jurjus A; Spinelli G; Lo Monte AI; Raimondo D J Biol Regul Homeost Agents; 2013; 27(4):919-33. PubMed ID: 24382173 [TBL] [Abstract][Full Text] [Related]
4. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease? Seksik P; Dray X; Sokol H; Marteau P Mol Nutr Food Res; 2008 Aug; 52(8):906-12. PubMed ID: 18384087 [TBL] [Abstract][Full Text] [Related]
5. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Hedin C; Whelan K; Lindsay JO Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082 [TBL] [Abstract][Full Text] [Related]
7. Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going? Naseer M; Poola S; Ali S; Samiullah S; Tahan V Curr Clin Pharmacol; 2020; 15(3):216-233. PubMed ID: 32164516 [TBL] [Abstract][Full Text] [Related]
8. Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease. Wasilewski A; Zielińska M; Storr M; Fichna J Inflamm Bowel Dis; 2015 Jul; 21(7):1674-82. PubMed ID: 25822014 [TBL] [Abstract][Full Text] [Related]
10. Inulin and fructo-oligosaccharides have divergent effects on colitis and commensal microbiota in HLA-B27 transgenic rats. Koleva PT; Valcheva RS; Sun X; Gänzle MG; Dieleman LA Br J Nutr; 2012 Nov; 108(9):1633-43. PubMed ID: 22243836 [TBL] [Abstract][Full Text] [Related]
11. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet? Serban DE Nutr Clin Pract; 2015 Dec; 30(6):760-79. PubMed ID: 26452390 [TBL] [Abstract][Full Text] [Related]
12. Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children. Guandalini S; Cernat E; Moscoso D Benef Microbes; 2015; 6(2):209-17. PubMed ID: 25391345 [TBL] [Abstract][Full Text] [Related]
13. Enteric microbiota leads to new therapeutic strategies for ulcerative colitis. Chen WX; Ren LH; Shi RH World J Gastroenterol; 2014 Nov; 20(42):15657-63. PubMed ID: 25400449 [TBL] [Abstract][Full Text] [Related]
14. Recent progress on the role of gut microbiota in the pathogenesis of inflammatory bowel disease. Yu CG; Huang Q J Dig Dis; 2013 Oct; 14(10):513-7. PubMed ID: 23848393 [TBL] [Abstract][Full Text] [Related]
15. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease. Wang ZK; Yang YS; Chen Y; Yuan J; Sun G; Peng LH World J Gastroenterol; 2014 Oct; 20(40):14805-20. PubMed ID: 25356041 [TBL] [Abstract][Full Text] [Related]
16. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again? Satokari R Scand J Gastroenterol; 2015 Jan; 50(1):34-42. PubMed ID: 25523554 [TBL] [Abstract][Full Text] [Related]
18. Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease. Ghouri YA; Richards DM; Rahimi EF; Krill JT; Jelinek KA; DuPont AW Clin Exp Gastroenterol; 2014; 7():473-87. PubMed ID: 25525379 [TBL] [Abstract][Full Text] [Related]
19. Probiotics and antibiotics in IBD. Sokol H Dig Dis; 2014; 32 Suppl 1():10-7. PubMed ID: 25531348 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered. Qiao YQ; Cai CW; Ran ZH J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]